Published Work on VAERS

Here are some of my most recent publications using VAERS data.

VAERS descriptive analysis

Published: May 2021

Rose, J. 2021. A report on US Vaccine Adverse Events Reporting System (VAERS) of the COVID-19 messenger ribonucleic acid (mRNA) biologicals. Science, Public Health Policy & the Law. 2:59-80.

Screen Shot 2022-01-24 at 21.15_edited.jpg

Critical appraisal of VAERS

Published: October 2021

Rose, J. 2021, Critical Appraisal of VAERS Pharmacovigilance: Is
the U.S. Vaccine Adverse Events Reporting System (VAERS) a Functioning Pharmacovigilance System? Science, Public Health Policy & the Law
Volume 3:100–129.

Screen Shot 2022-01-24 at 21.23.55.png

A report on Myocarditis in VAERS

Published: October 2021

Jessica Rose PhD, MSc, BSc , Peter A. McCullough MD, MPH. A Report
on Myocarditis Adverse Events in the U.S. Vaccine Adverse Events Reporting System (VAERS) in Association with COVID-19 Injectable Biological Products, Current Problems in Cardiology (2021), doi: https://doi.org/10.1016

Myocarditis in VAERS